Published in Blood Weekly, May 13th, 1996
The results, published in the May 1, 1996, issue of Blood, further showed that mice given drug-resistant human tumors were completely cured when treated with Oncolysin B followed by a combination of conventional chemotherapeutic agents. These findings are especially important because multi-drug resistance in tumors is a major limitation in the successful treatment of many cancers.
ImmunoGen is conducting a Phase II human clinical study to test the potential benefits of using Oncolysin B in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.